A subsidiary of Glenmark Pharma, Glenmark Lifescience IPO, got fully subscribed within two hours of opening. The IPO received a strong response from all investors, especially the retail segment, who led the charge by oversubscribing on the first day. Glenmark Lifescience is the subsidiary of the listed Glenmark Pharmaceutical, manufacturers critical non-commoditized APIs for chronic …


